Singapore: Bayer Korea recently announced the appointment of Ms Ingrid Drechsel as its new CEO. The company said in a st...
Singapore: Taiwan based TWi Biotechnology has been granted patent in Korea for it diabetes drug, AC-201, from the Korean...
Singapore: South Korean biopharmaceutical company, Green Cross, is expanding its presence in China by building a cell th...
Singapore: Singapore-Stanford Biodesign (SSB) has inked a three-year pact with Korea's Dongguk University (DU) to train ...
Singapore: With a view to bolster the country's burgeoning biotech sector, the South Korean government recently announce...
South Korean publicly listed bioscience companies in 2013 registered combined revenue of $8.3 billion. The leading pu...
Singapore: Australia based global medical technology company, Anteo Diagnostics, has entered into a non-exclusive distri...
Singapore:The latest in a string of scandals related to Novartis comes from Korea. As reported by the Korean Herald, six...
Singapore: Seegene has developed a novel real-time array technology designed specifically to accelerate the development ...
Singapore: Endoscopy devices market in Australia, South Korea, and Southeast Asia, earned revenues of USD264.7 million i...
Singapore: Korea's leading CRO, LSK Global has expanded its use of Medidata Clinical cloud platform, thus strengthening ...
Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerab...
Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commer...
Singapore: In a bid to boost its biotech and nanotechnology sectors, South Korea has inked a $80 million pact with the E...
Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...
Singapore: Korea pharma giant, Samsung Bioepis, has successfully completed Phase 3 clinical study of SB5, an investigati...
Singapore: Vigilant Biosciences, developer of early detection and intervention technology for oral cancer, has entered i...
Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutica...
